Harvest Fund Management Co., LTD Biogen Inc. Transaction History

Harvest Fund Management Co., LTD

$2.14 Billion
Q4 2024

A detailed history of Harvest Fund Management Co., LTD transactions in Biogen Inc. stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 8,576 shares of BIIB stock, worth $1.17 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

8,576

Previous 6,710 27.81%

Holding current value

$1.17 Million

Previous $1.3 Million 0.85%

% of portfolio

0.06%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$146.47 - $191.55 $273,313 - $357,432	1,866 Added 27.81%	8,576 $1.31 Million
Q3 2024 Nov 12, 2024	BUY	$189.07 - $236.8 $435,617 - $545,587	2,304 Added 52.29%	6,710 $1.3 Million
Q2 2024 Aug 08, 2024	BUY	$190.52 - $236.72 $24,005 - $29,826	126 Added 2.94%	4,406 $1.02 Million
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $633,939 - $800,452	2,990 Added 231.78%	4,280 $922,000
Q4 2023 Feb 01, 2024	BUY	$222.59 - $267.94 $29,604 - $35,636	133 Added 11.5%	1,290 $333,000
Q3 2023 Nov 06, 2023	BUY	$253.3 - $285.89 $108,665 - $122,646	429 Added 58.93%	1,157 $297,000
Q2 2023 Jul 07, 2023	BUY	$275.25 - $318.06 $55,050 - $63,612	200 Added 37.88%	728 $207,000
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $7,953 - $9,062	-31 Reduced 5.55%	528 $147,000
Q4 2022 Feb 06, 2023	BUY	$252.44 - $306.72 $125,967 - $153,053	499 Added 831.67%	559 $154,000
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $5,451 - $7,516	28 Added 87.5%	60 $16,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $15,002 - $19,280	-67 Reduced 67.68%	32 $7,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $28,016 - $36,535	99 New	99 $28,000
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $17,246 - $25,960	-73 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$264.77 - $305.71 $19,328 - $22,316	73 New	73 $20,000
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $187,528 - $248,348	-725 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$268.85 - $341.04 $41,134 - $52,179	-153 Reduced 17.43%	725 $229,000
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $160,423 - $221,667	729 Added 489.26%	878 $257,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $105,240 - $118,037	-484 Reduced 76.46%	149 $35,000
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $76,751 - $84,602	350 Added 123.67%	633 $148,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $134,576 - $210,494	-621 Reduced 68.69%	283 $67,000
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $144,820 - $183,430	520 Added 135.42%	904 $272,000
Q3 2018 Oct 31, 2018	BUY	$293.51 - $383.83 $61,930 - $80,988	211 Added 121.97%	384 $136,000
Q4 2017 Jan 25, 2018	SELL	$307.64 - $344.58 $52,914 - $59,267	-172 Reduced 49.86%	173 $55,000
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $96,996 - $113,743	345	345 $108,000

Others Institutions Holding BIIB

# of Institutions

998

Shares Held

131M

Call Options Held

1.78M

Put Options Held

2.36M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $19.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.

Account

Harvest Fund Management Co., LTD Biogen Inc. Transaction History